| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | +46.8% |
| Cost of Revenue | $9.8M | +12.6% |
| R&D Expense | $1.5M | -61.2% |
| SG&A Expense | $18.0M | -21.3% |
| Operating Income | -$18.8M | +47.0% |
| Pre-tax Income | -$15.6M | +3.3% |
| Income Tax | $14K | +600.0% |
| Net Income | -$15.4M | -4.9% |
| EPS (Basic) | -$25.65 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.6M | -28.0% |
| Accounts Receivable | $1.3M | -6.1% |
| Inventory | $2.6M | -42.0% |
| Current Assets | $25.4M | -28.2% |
| Total Assets | $28.9M | -34.1% |
| Current Liabilities | $4.2M | -16.5% |
| Total Liabilities | $8.0M | -36.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.0M | +46.0% |
| Capital Expenditures | $72K | -92.9% |
| Investing Cash Flow | $1.4M | -91.5% |
| Financing Cash Flow | $4.5M | -79.4% |
| Free Cash Flow | -$14.0M | +47.7% |
| +6.9% |
| EPS (Diluted) | -$25.65 | +6.9% |
| Stockholders' Equity |
| $21.0M |
| -32.4% |